AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteProparacaine HCl is a voltage-gated sodium channels antagonist with ED50 of 3.4 mM.
More Information Supplier PageProparacaine HCl is a voltage-gated sodium channels antagonist with ED50 of 3.4 mM.
More Information Supplier PageProparacaine HCl is a voltage-gated sodium channels antagonist with ED50 of 3.4 mM.
More Information Supplier PageProscillaridin A is a cardiac glycoside first isolated from plants in the genus Scilla.
More Information Supplier PageProscillaridin A is a cardiac glycoside first isolated from plants in the genus Scilla.
More Information Supplier PageProscillaridin A is a cardiac glycoside first isolated from plants in the genus Scilla.
More Information Supplier PageProstaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-??-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.
More Information Supplier PageProstaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-??-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.
More Information Supplier PageProstaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-??-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.
More Information Supplier PageProstaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-??-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.
More Information Supplier PageProstaglandin E1 (PGE1) is the theoretical cyclooxygenase metabolite of dihomo-??-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM.
More Information Supplier PageProstratin is a protein kinase C activator found in the bark of the mamala tree of Samoa, Homalanthus nutans.
More Information Supplier PageProstratin is a protein kinase C activator found in the bark of the mamala tree of Samoa, Homalanthus nutans.
More Information Supplier PageProstratin is a protein kinase C activator found in the bark of the mamala tree of Samoa, Homalanthus nutans.
More Information Supplier PageProtodioscin is a steroidal saponin found in Tribulus terrestris and other plants.
More Information Supplier PageProtodioscin is a steroidal saponin found in Tribulus terrestris and other plants.
More Information Supplier PageProtodioscin is a steroidal saponin found in Tribulus terrestris and other plants.
More Information Supplier PageProtopanaxatriol is an organic compound characterizing a group of ginsenosides.
More Information Supplier PageProtopanaxatriol is an organic compound characterizing a group of ginsenosides.
More Information Supplier PageProtopanaxatriol is an organic compound characterizing a group of ginsenosides.
More Information Supplier PageProtopine is a benzylisoquinoline alkaloid occurring in opium poppy, Corydalis tubers and other plants of the family papaveraceae, like Fumaria officinalis.
More Information Supplier PageProtopine is a benzylisoquinoline alkaloid occurring in opium poppy, Corydalis tubers and other plants of the family papaveraceae, like Fumaria officinalis.
More Information Supplier PageProtopine is a benzylisoquinoline alkaloid occurring in opium poppy, Corydalis tubers and other plants of the family papaveraceae, like Fumaria officinalis.
More Information Supplier PagePRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types.
More Information Supplier PagePRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types.
More Information Supplier PagePRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types.
More Information Supplier PagePRT-060318 is a novel selective inhibitor of the tyrosine kinase Syk, as an approach to HIT treatment.
More Information Supplier PagePRT-060318 is a novel selective inhibitor of the tyrosine kinase Syk, as an approach to HIT treatment.
More Information Supplier PagePRT-060318 is a novel selective inhibitor of the tyrosine kinase Syk, as an approach to HIT treatment.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePrucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.
More Information Supplier PagePrucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.
More Information Supplier PagePrucalopride is a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.
More Information Supplier Page
